Brilique anti-platelet drug. Brilique contains the active ingredient ticagrelor, which reversibly blocks adenosine diphosphate (ADP) receptors and inh

---

Brilique anti-platelet drug. Brilique contains the active ingredient ticagrelor, which reversibly blocks adenosine diphosphate (ADP) receptors and inhibits platelet aggregation and clot formation. It is used in the prevention of strokes and heart attacks caused by clots.

---

Size: 5634px × 3756px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: -, -life, 1, acs, acute, aggregation, anti-clotting, antiplatelet, artery, attack, background, biochemical, biochemistry, blood, brilinta, brilique, cerebrovascular, chemical, chemistry, close, close-, clot, clotting, coronary, cut, cut-, cut-outs, cutout, cutouts, detail, disease, dose, drug, drugs, healthcare, heart, inhibition, inhibitor, life, medical, medication, medicine, oral, outs, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pill, platelet, possia, prescribed, prescription, single, stroke, syndrome, tablet, thrombosis, thrombus, ticagrelor, treatment, white